drugset / Trial / NCT02092038

Preoperative Chemoradiation for Glioblastoma

NCT02092038 ↗

Phase 1 Completed 1 enrolled Tampa General Hospital
NaSingle-groupOpen-labelTreatment

Summary

Trial to determine the safety of neoadjuvant treatment with concurrent temozolomide and radiation therapy, followed by surgery and then further temozolomide.

Timeline

Start
2014-11
Primary completion
2015-07
Completion
2015-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Temozolomide Small molecule — —

Indications